Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring.

Koole D, Heyligers J, Moll FL, Pasterkamp G.

J Cardiovasc Med (Hagerstown). 2012 Oct;13(10):635-9. doi: 10.2459/JCM.0b013e3283590cd2. Review.

PMID:
22955205
2.

From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages.

Michel JB, Delbosc S, Ho-Tin-Noé B, Leseche G, Nicoletti A, Meilhac O, Martin-Ventura JL.

J Cardiovasc Med (Hagerstown). 2012 Oct;13(10):628-34. doi: 10.2459/JCM.0b013e328357face. Review.

PMID:
22929566
3.

Imaging of intraplaque haemorrhage.

Prati F, Di Vito L.

J Cardiovasc Med (Hagerstown). 2012 Oct;13(10):640-4. doi: 10.2459/JCM.0b013e328357a665. Review.

PMID:
22955206
4.

Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability.

Chistiakov DA, Orekhov AN, Bobryshev YV.

Acta Physiol (Oxf). 2015 Mar;213(3):539-53. doi: 10.1111/apha.12438. Epub 2015 Jan 2. Review.

PMID:
25515699
5.

Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages.

Michel JB, Martin-Ventura JL, Nicoletti A, Ho-Tin-Noé B.

Atherosclerosis. 2014 Jun;234(2):311-9. doi: 10.1016/j.atherosclerosis.2014.03.020. Epub 2014 Mar 27. Review.

PMID:
24726899
6.

Pathology of plaque haemorrhage and neovascularization of coronary artery.

Kodama T, Narula N, Agozzino M, Arbustini E.

J Cardiovasc Med (Hagerstown). 2012 Oct;13(10):620-7. doi: 10.2459/JCM.0b013e328356a5f2. Review.

PMID:
22828775
7.

Multi-modal imaging technologies in cardiovascular risk assessment.

Casciani E, De Vincentiis C, Colaiacomo MC, Gualdi GF.

Ther Apher Dial. 2013 Apr;17(2):138-49. doi: 10.1111/j.1744-9987.2012.01132.x. Epub 2012 Oct 30. Review.

PMID:
23551670
8.

Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events.

Peeters W, de Kleijn DP, Vink A, van de Weg S, Schoneveld AH, Sze SK, van der Spek PJ, de Vries JP, Moll FL, Pasterkamp G.

Eur Heart J. 2011 Jul;32(14):1758-68. doi: 10.1093/eurheartj/ehq387. Epub 2010 Nov 8.

PMID:
21059735
9.

Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events.

Willems S, Vink A, Bot I, Quax PH, de Borst GJ, de Vries JP, van de Weg SM, Moll FL, Kuiper J, Kovanen PT, de Kleijn DP, Hoefer IE, Pasterkamp G.

Eur Heart J. 2013 Dec;34(48):3699-706. doi: 10.1093/eurheartj/eht186. Epub 2013 Jun 11.

PMID:
23756333
10.

Detection of adventitial vasa vasorum and intraplaque neovascularization in carotid atherosclerotic lesions with contrast-enhanced ultrasound and their role in atherosclerosis.

Partovi S, Loebe M, Noon GP, Davies MG, Karimi S, Zipp L, Feinstein SB, Staub D.

Methodist Debakey Cardiovasc J. 2011 Oct-Dec;7(4):37-40. Review.

PMID:
22143476
11.

Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.

Corti R.

Pharmacol Ther. 2006 Apr;110(1):57-70. Epub 2006 Jan 30. Review.

PMID:
16445985
12.

Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis.

Giannarelli C, Ibanez B, Cimmino G, Garcia Ruiz JM, Faita F, Bianchini E, Zafar MU, Fuster V, Garcia MJ, Badimon JJ.

JACC Cardiovasc Imaging. 2010 Dec;3(12):1256-64. doi: 10.1016/j.jcmg.2010.09.017.

13.

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.

Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2054-61. Epub 2005 Jul 21. Review.

14.

Atherosclerotic plaque rupture and intraplaque hemorrhage do not correlate with symptoms in carotid artery stenosis.

Milei J, Parodi JC, Ferreira M, Barrone A, Grana DR, Matturri L.

J Vasc Surg. 2003 Dec;38(6):1241-7.

15.

CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.

Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Lesèche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM.

J Am Coll Cardiol. 2008 Oct 14;52(16):1302-11. doi: 10.1016/j.jacc.2008.07.032.

16.

Current diagnostic modalities for vulnerable plaque detection.

Schaar JA, Mastik F, Regar E, den Uil CA, Gijsen FJ, Wentzel JJ, Serruys PW, van der Stehen AF.

Curr Pharm Des. 2007;13(10):995-1001. Review.

PMID:
17430163
17.

Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.

de Nooijer R, Verkleij CJ, von der Thüsen JH, Jukema JW, van der Wall EE, van Berkel TJ, Baker AH, Biessen EA.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):340-6. Epub 2005 Nov 23.

18.

Neovascularization in human atherosclerosis.

Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V.

Curr Mol Med. 2006 Aug;6(5):457-77. Review.

PMID:
16918368
19.

Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study.

van den Bouwhuijsen QJ, Vernooij MW, Hofman A, Krestin GP, van der Lugt A, Witteman JC.

Eur Heart J. 2012 Jan;33(2):221-9. doi: 10.1093/eurheartj/ehr227. Epub 2011 Aug 6.

PMID:
21821844
20.

Angiogenesis as risk factor for plaque vulnerability.

Di Stefano R, Felice F, Balbarini A.

Curr Pharm Des. 2009;15(10):1095-106. Review.

PMID:
19355951

Supplemental Content

Support Center